Search Results - "Messmer, Marcus R."

Rescue of Obesity-Induced Infertility in Female Mice due to a Pituitary-Specific Knockout of the Insulin Receptor by Brothers, Kathryn J., Wu, Sheng, DiVall, Sara A., Messmer, Marcus R., Kahn, C. Ronald, Miller, Ryan S., Radovick, Sally, Wondisford, Fredric E., Wolfe, Andrew

“…Obesity is associated with insulin resistance in metabolic tissues such as adipose, liver, and muscle, but it is unclear whether nonclassical target tissues,…”
Get full text

Outcomes of patients with limited‐stage plasmablastic lymphoma: A multi‐institutional retrospective study by Hess, Brian T., Giri, Anshu, Park, Yeonhee, Patel, Krina K., Link, Brian K., Nowakowski, Grzegorz S., Maliske, Seth M., Fortin, Sonia, Chavez, Julio C., Saeed, Hayder, Hill, Brian T., Mejia Garcia, Alex V., Maddocks, Kami J., Hanel, Walter, Wagner‐Johnston, Nina D., Messmer, Marcus R., Kahl, Brad S., Watkins, Marcus, Alderuccio, Juan Pablo, Lossos, Izidore S., Nathan, Sunita, Orellana‐Noia, Victor M., Portell, Craig A., Landsburg, Daniel J., Ayers, Emily C., Castillo, Jorge J.

“…Plasmablastic lymphoma (PBL) is a rare entity, commonly associated with immunosuppressed states such as human immunodeficiency virus (HIV) infection or solid…”
Get full text

Brentuximab vedotin plus AVD for Hodgkin lymphoma: incidence and management of peripheral neuropathy in a multisite cohort by Bowers, Jackson T., Anna, Jacob, Bair, Steven M., Annunzio, Kaitlin, Epperla, Narendranath, Pullukkara, Jerrin Joy, Gaballa, Sameh, Spinner, Michael A., Li, Shuning, Messmer, Marcus R., Nguyen, Joseph, Ayers, Emily C., Wagner, Charlotte B., Hu, Boyu, Di, Mengyang, Huntington, Scott F., Furqan, Fateeha, Shah, Nirav N., Chen, Christina, Ballard, Hatcher J., Hughes, Mitchell E., Chong, Elise A., Nasta, Sunita D., Barta, Stefan K., Landsburg, Daniel J., Svoboda, Jakub

“…•Most patients receiving BV plus AVD reported neuropathy, leading to BV discontinuation in 23%, a rate higher than that described in trials.•BV discontinuation…”
Get full text

Live Lymphoma and CLL Cells inside the Bone Marrow Fibroblasts: Implication in Residual Disease Persistence by Wang, Y. Lynn, Frazen, Carrie, Efimov, Andrey, Patel, Priyal, Lu, Pin, Ma, Shuo, Carrol, Katherine Amira, Cukierman, Edna, Messmer, Marcus R., Franco-Barraza, Janusz, Gao, Juehua, Vistarop, Aldana

“…Bruton tyrosine kinase inhibitors (BTKi) have generated remarkable clinical responses in patients with chronic lymphocytic leukemia (CLL) and other mature…”
Get full text

Multicenter Study of Mantle Cell Lymphoma Outcomes Following First-Line Bendamustine-Rituximab and Second-Line Bruton's Tyrosine Kinase Inhibitor Therapy by Wang, Yucai, Larson, Melissa C., Hwang, Steven R., Kumar, Anita, Joseph, Ashlee, Hill, Brian T., Brooks, Taylor R., Bond, David A., Maddocks, Kami J., Danilov, Alexey, McCarthy, Christine, Ruan, Jia, Nizamuddin, Imran A., Kahl, Brad S., Grover, Natalie S., Khan, Nazneen B., Ouchveridze, Evguenia, Tun, Aung M., Young, Philip, Portell, Craig A., Harris, Zoey I., Munoz, Javier L., Reagan, Patrick M., Pongas, Georgio, Lossos, Izidore S., Ryan, Christine E., Merryman, Reid W., Baidoun, Firas, Alhaj Moustafa, Muhamad, Gerber, Drew, Ayyappan, Sabarish R., Link, Brian K., Velayati, Arash, Greenwell, Irl Brian, Banaszak, Lauren G, Pophali, Priyanka A, Stack, Anthony C., Messmer, Marcus R., Narkhede, Mayur, Mehta, Amitkumar N., Jain, Preetesh, Wang, Michael L., Moyo, Tamara K., Ghosh, Nilanjan, Bhansali, Rahul S., Barta, Stefan K., Kamdar, Manali K., Anna, Jacob, Stanisic, Alexander V., Karmali, Reem, Kugathasan, Laveniya, Villa, Diego, Maurer, Matthew J., Cerhan, James R., Cohen, Jonathon B., Martin, Peter

“…Background: Bendamustine and rituximab (BR) is a standard-of-care first-line (1L) therapy for older or unfit patients with mantle cell lymphoma (MCL). The…”
Get full text